Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
95.69%
-
Total 13F principal
-
$260,852,606
-
Principal change
-
-$21,197,911
-
Total reported market value
-
$249,723,972
-
Number of holders
-
34
-
Value change
-
-$20,439,939
-
Number of buys
-
14
-
Number of sells
-
17
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q1 2015
As of 31 Mar 2015,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
34 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$260,852,606
in principal (par value) of the bond.
The largest 10 bondholders included
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, CNH PARTNERS LLC, WELLS FARGO & COMPANY/MN, PIONEER INVESTMENT MANAGEMENT INC, BASSO CAPITAL MANAGEMENT, L.P., WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, and ZAZOVE ASSOCIATES LLC.
This page lists
34
institutional bondholders reporting positions
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.